Skip to content

Effect of Respiratory Exercises With Pelvic Floor Rehab on Dyspareunia & Autonomic Function in Women

Not yet recruitingNot applicableNCT07078318
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Background and Aim: Dyspareunia, or pain during sexual intercourse, is a common component of female sexual dysfunction and may have multifactorial origins, including musculoskeletal and autonomic factors. While pelvic floor rehabilitation is an established treatment approach for musculoskeletal dyspareunia, it may not sufficiently address the autonomic dysregulation commonly observed in chronic pain conditions. The aim of this study is to investigate the effects of adding diaphragmatic breathing exercises and diaphragm manual therapy to standard pelvic floor rehabilitation on pain severity, pelvic floor function, and autonomic nervous system regulation in women diagnosed with musculoskeletal-origin dyspareunia. Methods: This randomized controlled clinical trial will be conducted between September 1, 2025, and December 1, 2025, at the Kurbaa Training and Consultation Center in Istanbul. A total of 45 participants aged 18-45 years who meet the inclusion criteria will be randomly assigned into three equal groups (n = 15): Group I: Pelvic floor rehabilitation only Group II: Pelvic floor rehabilitation + diaphragmatic breathing exercises Group III: Pelvic floor rehabilitation + diaphragmatic breathing exercises + diaphragm manual therapy Interventions will be administered once per week for 8 weeks. Pre- and post-intervention assessments will include pain intensity (Visual Analog Scale), pelvic floor muscle function (ultrasonography), sexual function (Female Sexual Function Index), anxiety level (Beck Anxiety Inventory), and autonomic regulation (Heart Rate Variability using Elite HRV). Statistical analyses will be performed using SPSS with significance set at p \< 0.05. Expected Contribution: This study is expected to contribute to the development of more comprehensive treatment protocols for dyspareunia by integrating physical and neurophysiological rehabilitation components. It may also provide evidence supporting the role of autonomic regulation in improving treatment…

Study details

Official title
The Effect of Respiratory Exercises Given in Addition to Pelvic Floor Rehabilitation on Dyspareunia and Autonomic Nervous System in Women With Musculoskeletal Dyspareunia
Conditions
Interventions
  • Other: Pelvic floor rehabilitation
  • Other: Diaphragmatic Breathing Exercises
  • Other: Diaphragm Manual Therapy
Sponsor
Sakarya Applied Sciences University
Start date
2025-09-01
Primary completion
2026-07-01
Sex
Female
Age range
from 18 Years to 45 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Female participants aged between 18 and 45 years Experiencing dyspareunia of musculoskeletal origin for at least 6 months In a stable sexual relationship and sexually active Willing and able to attend weekly treatment sessions for 8 weeks Able to provide informed consent No pelvic surgery within the last 6 months Normal cognitive function and ability to follow instructions Baseline FSFI score indicating sexual dysfunction (e.g., ≤ 26.55) Exclusion Criteria: * Presence of neurological, gynecological, or urological pathologies causing pelvic pain (e.g., endometriosis, pelvic inflammatory disease) Pregnancy or postpartum period within the last 6 months Diagnosed psychiatric disorders (e.g., major depression, psychosis) Use of medications that affect autonomic nervous system function (e.g., beta-blockers, antidepressants) History of pelvic radiation, cancer, or pelvic trauma Participation in other rehabilitation or psychotherapy programs during the study period Inability to tolerate manual therapy or perform breathing exercises BMI \> 35, which may interfere with ultrasonographic assessment Non-compliance risk, such as irregular attendance or language barriers

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07078318